Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Lucia Vellutini Pimentel

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Arquivos De Neuro-Psiquiatria|April 9, 2013
Natalizumab and multiple sclerosisMaria Lucia Vellutini Pimentel
Arquivos De Neuro-Psiquiatria|October 6, 2016
Olfactory dysfunction as a marker of multiple sclerosis progressionMaria Lucia Vellutini Pimentel
Arquivos De Neuro-Psiquiatria|August 8, 2014
Neuromyelitis optica spectrum disorder and Sjögren syndrome are overlapping disorders and participate in the same autoimmunity context?Maria Lucia Vellutini Pimentel
Arquivos De Neuro-Psiquiatria|October 22, 2013
Multiple sclerosis in the Southern and Northern hemispheres: the month of birth at different latitudes has the same influence on the prevalence and progression of the disease in the Northern and Southern hemispheres?Maria Lucia Vellutini Pimentel
Arquivos De Neuro-Psiquiatria|October 25, 2008
Immune system markers of neuroinflammation in patients with clinical diagnose of neuromyelitis opticaSoniza Vieira Alves-Leon, Maria Lucia Vellutini Pimentel, Gabrielle Sant'Anna, et al.
Cureus|April 10, 2025
Predictors of Response to Treatment With Anti-calcitonin Gene-Related Peptide (CGRP) Antibodies in Real-World Patients With Episodic Migraine: A Two- and Four-Month Prospective StudyAbouch Krymchantowski, Carla Jevoux, Raimundo P Silva-Néto, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|November 7, 2018
Seroconversion of JCV antibodies is strongly associated to natalizumab therapyYara Dadalti Fragoso, Joseph B Bidin Brooks, Audred C Biondo Eboni, et al.
Arquivos De Neuro-Psiquiatria|October 27, 2018
Serological profile of John Cunningham virus (JCV) in patients with multiple sclerosisLuciana Prats Branco, Tarso Adoni, Samira Luisa Apostolos-Pereira, et al.
Arquivos De Neuro-Psiquiatria|November 24, 2021
Recommendations by the Scientific Department of Neuroimmunology of the Brazilian Academy of Neurology (DCNI/ABN) and the Brazilian Committee for Treatment and Research in Multiple Sclerosis and Neuroimmunological Diseases (BCTRIMS) on vaccination in general and specifically against SARS-CoV-2 for patients with demyelinating diseases of the central nervous systemJefferson Becker, Lis Campos Ferreira, Alfredo Damasceno, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|August 27, 2021
Clinical Features of COVID-19 on Patients With Neuromyelitis Optica Spectrum DisordersSamira Luisa Apostolos-Pereira, Lis Campos Ferreira, Mateus Boaventura, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Arquivos De Neuro-Psiquiatria|April 9, 2013
Natalizumab and multiple sclerosisMaria Lucia Vellutini Pimentel
Arquivos De Neuro-Psiquiatria|October 6, 2016
Olfactory dysfunction as a marker of multiple sclerosis progressionMaria Lucia Vellutini Pimentel
Arquivos De Neuro-Psiquiatria|August 8, 2014
Neuromyelitis optica spectrum disorder and Sjögren syndrome are overlapping disorders and participate in the same autoimmunity context?Maria Lucia Vellutini Pimentel
Arquivos De Neuro-Psiquiatria|October 22, 2013
Multiple sclerosis in the Southern and Northern hemispheres: the month of birth at different latitudes has the same influence on the prevalence and progression of the disease in the Northern and Southern hemispheres?Maria Lucia Vellutini Pimentel
Arquivos De Neuro-Psiquiatria|October 25, 2008
Immune system markers of neuroinflammation in patients with clinical diagnose of neuromyelitis opticaSoniza Vieira Alves-Leon, Maria Lucia Vellutini Pimentel, Gabrielle Sant'Anna, et al.
Cureus|April 10, 2025
Predictors of Response to Treatment With Anti-calcitonin Gene-Related Peptide (CGRP) Antibodies in Real-World Patients With Episodic Migraine: A Two- and Four-Month Prospective StudyAbouch Krymchantowski, Carla Jevoux, Raimundo P Silva-Néto, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|November 7, 2018
Seroconversion of JCV antibodies is strongly associated to natalizumab therapyYara Dadalti Fragoso, Joseph B Bidin Brooks, Audred C Biondo Eboni, et al.
Arquivos De Neuro-Psiquiatria|October 27, 2018
Serological profile of John Cunningham virus (JCV) in patients with multiple sclerosisLuciana Prats Branco, Tarso Adoni, Samira Luisa Apostolos-Pereira, et al.
Arquivos De Neuro-Psiquiatria|November 24, 2021
Recommendations by the Scientific Department of Neuroimmunology of the Brazilian Academy of Neurology (DCNI/ABN) and the Brazilian Committee for Treatment and Research in Multiple Sclerosis and Neuroimmunological Diseases (BCTRIMS) on vaccination in general and specifically against SARS-CoV-2 for patients with demyelinating diseases of the central nervous systemJefferson Becker, Lis Campos Ferreira, Alfredo Damasceno, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|August 27, 2021
Clinical Features of COVID-19 on Patients With Neuromyelitis Optica Spectrum DisordersSamira Luisa Apostolos-Pereira, Lis Campos Ferreira, Mateus Boaventura, et al.
Pageof 1